| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.017 | 0.9 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.016 | 0.9 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.015 | 0.9 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |